DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
7.04
-0.18 (-2.49%)
At close: Jun 30, 2026, 4:00 PM EDT
7.14
+0.10 (1.42%)
After-hours: Jun 30, 2026, 4:37 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $379.34 million as of June 30, 2026. Its market cap has increased by 142.39% in one year.
Market Cap
379.34M
Enterprise Value
328.22M
1-Year Change
142.39%
Ranking
Category
Stock Price
$7.04
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $379.34M, an increase of 933.62%. That is a compound annual growth rate of 36.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 379.34M | -8.48% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 416.87M |
| X4 Pharmaceuticals | 398.97M |
| Compass Therapeutics | 388.99M |
| Palisade Bio | 387.08M |
| Fennec Pharmaceuticals | 383.15M |
| Lexeo Therapeutics | 377.69M |
| Upstream Bio | 377.13M |
| OmniAb | 372.58M |